Clinical influence of conversion of laparoscopic sleeve gastrectomy to one anastomosis gastric bypass on gastroesophageal reflux disease.


Journal

Langenbeck's archives of surgery
ISSN: 1435-2451
Titre abrégé: Langenbecks Arch Surg
Pays: Germany
ID NLM: 9808285

Informations de publication

Date de publication:
27 Apr 2023
Historique:
received: 19 09 2022
accepted: 10 04 2023
medline: 1 5 2023
pubmed: 27 4 2023
entrez: 27 4 2023
Statut: epublish

Résumé

Assess the subjective impact of gastro-esophageal reflux disease (GERD) symptoms on patients undergoing revision from laparoscopic sleeve gastrectomy (LSG) to one-anastomosis gastric bypass (OAGB) using the Reflux Disease Questionnaire for GERD (RDQ) and the GERD-health related quality of life score (GERD-HRQL), prior to- and following conversion. Patients undergoing revision from LSG to OAGB were prospectively followed between May 2015 and December 2020. Data retrieved included demographics, anthropometrics, previous bariatric history, time interval between LSG and OAGB, weight loss, and co-morbidities. Pre- and post-OAGB RDQ and GERD-HRQL questionnaires were obtained. In the case of sleeve dilatation, sleeve resizing was performed. During the study period, 37 patients underwent revision from LSG to OAGB. Mean ages at LSG and pre-OAGB were 38 ± 11.74 and 46 ± 12.75, respectively. Median follow-up time was 21.5 months (range 3-65). All patients underwent sleeve resizing. RDQ and GERD-HRQL scores were obtained at a median of 14 months (range 3-51) between pre- and post-OAGB. Median RDQ score pre-OAGB vs post-OAGB was significantly reduced (30 (range 12-72) vs 14 (range 12-60), p = 0.007). All 3 parts of the GERD- HRQL questionnaires were significantly reduced between pre-OAGB and post-OAGB: Symptoms (20; 62.5% vs 10; 31.3%, p = 0.012), overall score (15 (0-39) vs 7 (0-28), p = 0.04) and subjective improvement (10; 31% vs 20; 62.5%, p = 0.025). Conversion of LSG to OAGB showed subjective improvement of GERD symptoms both in RDQ and in GERD-HRQL.

Identifiants

pubmed: 37103604
doi: 10.1007/s00423-023-02892-7
pii: 10.1007/s00423-023-02892-7
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

163

Informations de copyright

© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Références

Welbourn R, Hollyman M, Kinsman R et al (2019) Bariatric surgery worldwide: baseline demographic description and one-year outcomes from the Fourth IFSO Global Registry Report 2018. Obes Surg 29:782–795. https://doi.org/10.1007/s11695-018-3593-1
doi: 10.1007/s11695-018-3593-1 pubmed: 30421326
Altieri MS, Yang J, Nie L et al (2018) Rate of revisions or conversion after bariatric surgery over 10 years in the state of New York. Surg Obes Relat Dis 14:500–507. https://doi.org/10.1016/j.soard.2017.12.019
doi: 10.1016/j.soard.2017.12.019 pubmed: 29496440
Lazzati A, Bechet S, Jouma S et al (2020) Revision surgery after sleeve gastrectomy: a nationwide study with 10 years of follow-up. Surg Obes Relat Dis 16:1497–1504. https://doi.org/10.1016/j.soard.2020.05.021
doi: 10.1016/j.soard.2020.05.021 pubmed: 32636173
Clapp B, Wynn M, Martyn C et al (2018) Long term (7 or more years) outcomes of the sleeve gastrectomy: a meta-analysis. Surg Obes Relat Dis 14:741–747. https://doi.org/10.1016/j.soard.2018.02.027
doi: 10.1016/j.soard.2018.02.027 pubmed: 29625744
Iannelli A, Debs T, Martini F et al (2016) Laparoscopic conversion of sleeve gastrectomy to Roux-en-Y gastric bypass: indications and preliminary results. Surg Obes Relat Dis 12:1533–1538. https://doi.org/10.1016/j.soard.2016.04.008
doi: 10.1016/j.soard.2016.04.008 pubmed: 27425833
Homan J, Betzel B, Aarts EO et al (2015) Secondary surgery after sleeve gastrectomy: Roux-en-Y gastric bypass or biliopancreatic diversion with duodenal switch. Surg Obes Relat Dis 11:771–777. https://doi.org/10.1016/j.soard.2014.09.029
doi: 10.1016/j.soard.2014.09.029 pubmed: 25769402
Langer FB, Bohdjalian A, Shakeri-Leidenmühler S et al (2010) Conversion from sleeve gastrectomy to roux-en-y gastric bypass-indications and outcome. Obes Surg 20:835–840. https://doi.org/10.1007/s11695-010-0125-z
doi: 10.1007/s11695-010-0125-z pubmed: 20393810
Rayman S, Assaf D, Azran C, et al (2021) Sleeve gastrectomy failure—revision to laparoscopic one-anastomosis gastric bypass or Roux-n-Y gastric bypass: a multicenter study. Obes Surg 3–10. https://doi.org/10.1007/s11695-021-05334-9
Laffin M, Chau J, Gill RS, et al (2013) Sleeve gastrectomy and gastroesophageal reflux disease. J Obes 2013:. https://doi.org/10.1155/2013/741097
Kowalewski PK, Olszewski R, Walędziak MS et al (2018) Long-term outcomes of laparoscopic sleeve gastrectomy—a single-center, retrospective study. Obes Surg 28:130–134. https://doi.org/10.1007/s11695-017-2795-2
doi: 10.1007/s11695-017-2795-2 pubmed: 28707172
Mandeville Y, Van Looveren R, Vancoillie PJ et al (2017) Moderating the enthusiasm of sleeve gastrectomy: up to fifty percent of reflux symptoms after ten years in a consecutive series of one hundred laparoscopic sleeve gastrectomies. Obes Surg 27:1797–1803. https://doi.org/10.1007/s11695-017-2567-z
doi: 10.1007/s11695-017-2567-z pubmed: 28190216
Rutledge R (2001) The mini-gastric bypass: experience with the first 1,274 cases. Obes Surg 11:276–280. https://doi.org/10.1381/096089201321336584
doi: 10.1381/096089201321336584 pubmed: 11433900
Parmar CD, Bryant C, Luque-de-Leon E et al (2019) One anastomosis gastric bypass in morbidly obese patients with BMI ≥ 50 kg/m2: a systematic review comparing it with Roux-En-Y gastric bypass and sleeve gastrectomy. Obes Surg 29:3039–3046. https://doi.org/10.1007/s11695-019-04034-9
doi: 10.1007/s11695-019-04034-9 pubmed: 31250385
Lee WJ, Almalki OM, Ser KH et al (2019) Randomized controlled trial of one anastomosis gastric bypass versus Roux-En-Y gastric bypass for obesity: comparison of the YOMEGA and Taiwan studies. Obes Surg 29:3047–3053. https://doi.org/10.1007/s11695-019-04065-2
doi: 10.1007/s11695-019-04065-2 pubmed: 31290104
Jamal W, Zagzoog MM, Sait SH et al (2019) Initial outcomes of one anastomosis gastric bypass at a single institution. Diabetes Metab Syndr Obes 12:35–41. https://doi.org/10.2147/DMSO.S180111
doi: 10.2147/DMSO.S180111 pubmed: 30613157
Moszkowicz D, Rau C, Guenzi M et al (2013) Laparoscopic omega-loop gastric bypass for the conversion of failed sleeve gastrectomy: early experience. J Visc Surg 150:373–378. https://doi.org/10.1016/j.jviscsurg.2013.08.010
doi: 10.1016/j.jviscsurg.2013.08.010 pubmed: 24139677
Bruzzi M, Chevallier JM, Czernichow S (2017) One-anastomosis gastric bypass: why biliary reflux remains controversial? Obes Surg 27:545–547. https://doi.org/10.1007/s11695-016-2480-x
doi: 10.1007/s11695-016-2480-x pubmed: 27909875
Mahawar KK, Borg CM, Kular KS et al (2017) Understanding objections to one anastomosis (Mini) gastric bypass: a survey of 417 surgeons not performing this procedure. Obes Surg 27:2222–2228. https://doi.org/10.1007/s11695-017-2663-0
doi: 10.1007/s11695-017-2663-0 pubmed: 28361493
Shaw M, Dent J, Beebe T et al (2008) The reflux disease questionnaire: a measure for assessment of treatment response in clinical trials. Health Qual Life Outcomes 6:1–6. https://doi.org/10.1186/1477-7525-6-31
doi: 10.1186/1477-7525-6-31
Velanovich V (1998) Comparison of generic (SF-36) vs. disease-specific (GERD-HRQL) quality-of-life scales for gastroesophageal reflux disease. J Gastrointest Surg 2:141–145. https://doi.org/10.1016/s1091-255x(98)80004-8
doi: 10.1016/s1091-255x(98)80004-8 pubmed: 9834409
Kermansaravi M, Parmar C, Chiappetta S et al (2022) Patient selection in one anastomosis/mini gastric bypass—an expert modified delphi consensus. Obes Surg 32:2512–2524. https://doi.org/10.1007/s11695-022-06124-7
doi: 10.1007/s11695-022-06124-7 pubmed: 35704259
Clavien PA, Barkun J, de Oliveira ML et al (2009) The clavien-dindo classification of surgical complications: five-year experience. Ann Surg 250:187–196. https://doi.org/10.1097/SLA.0b013e3181b13ca2
doi: 10.1097/SLA.0b013e3181b13ca2 pubmed: 19638912
Yehoshua RT, Eidelman LA, Stein M et al (2008) Laparoscopic sleeve gastrectomy - volume and pressure assessment. Obes Surg 18:1083–1088. https://doi.org/10.1007/s11695-008-9576-x
doi: 10.1007/s11695-008-9576-x pubmed: 18535864
Braghetto I, Lanzarini E, Korn O et al (2010) Manometric changes of the lower esophageal sphincter after sleeve gastrectomy in obese patients. Obes Surg 20:357–362. https://doi.org/10.1007/s11695-009-0040-3
doi: 10.1007/s11695-009-0040-3 pubmed: 20013071
Himpens J, Dapri G, Cadière GB (2006) A prospective randomized study between laparoscopic gastric banding and laparoscopic isolated sleeve gastrectomy: results after 1 and 3 years. Obes Surg 16:1450–1456. https://doi.org/10.1381/096089206778869933
doi: 10.1381/096089206778869933 pubmed: 17132410
Chiu S, Birch DW, Shi X et al (2011) Effect of sleeve gastrectomy on gastroesophageal reflux disease: a systematic review. Surg Obes Relat Dis 7:510–515. https://doi.org/10.1016/j.soard.2010.09.011
doi: 10.1016/j.soard.2010.09.011 pubmed: 21130052
Del Genio G, Tolone S, Limongelli P et al (2014) Sleeve gastrectomy and development of “de novo” gastroesophageal reflux. Obes Surg 24:71–77. https://doi.org/10.1007/s11695-013-1046-4
doi: 10.1007/s11695-013-1046-4 pubmed: 24249251
Himpens J, Dobbeleir J, Peeters G (2010) Long-term results of laparoscopic sleeve gastrectomy for obesity. Ann Surg 252:319–324. https://doi.org/10.1097/SLA.0b013e3181e90b31
doi: 10.1097/SLA.0b013e3181e90b31 pubmed: 20622654
Tolone S, Cristiano S, Savarino E et al (2016) Effects of omega-loop bypass on esophagogastric junction function. Surg Obes Relat Dis 12:62–69. https://doi.org/10.1016/j.soard.2015.03.011
doi: 10.1016/j.soard.2015.03.011 pubmed: 25979206
Adil MT, Al-taan O, Rashid F et al (2019) A systematic review and meta-analysis of the effect of Roux-en-Y gastric bypass on barrett’s esophagus. Obes Surg 29:3712–3721. https://doi.org/10.1007/s11695-019-04083-0
doi: 10.1007/s11695-019-04083-0 pubmed: 31309524
Holmberg D, Santoni G, Xie S, Lagergren J (2019) Gastric bypass surgery in the treatment of gastro-oesophageal reflux symptoms. Aliment Pharmacol Ther 50:159–166. https://doi.org/10.1111/apt.15274
doi: 10.1111/apt.15274 pubmed: 31165515
Yorke E, Sheppard C, Switzer NJ et al (2017) Revision of sleeve gastrectomy to Roux-en-Y gastric bypass: a Canadian experience. Am J Surg 213:970–974. https://doi.org/10.1016/j.amjsurg.2017.04.003
doi: 10.1016/j.amjsurg.2017.04.003 pubmed: 28416180
Parmar CD, Mahawar KK, Boyle M et al (2017) Conversion of sleeve gastrectomy to Roux-en-Y gastric bypass is effective for gastro-oesophageal reflux disease but not for further weight loss. Obes Surg 27:1651–1658. https://doi.org/10.1007/s11695-017-2542-8
doi: 10.1007/s11695-017-2542-8 pubmed: 28063112
Landreneau JP, Strong AT, Rodriguez JH et al (2018) Conversion of Sleeve Gastrectomy to Roux-en-Y Gastric Bypass. Obes Surg 28:3843–3850. https://doi.org/10.1007/s11695-018-3435-1
doi: 10.1007/s11695-018-3435-1 pubmed: 30094577
Felsenreich DM, Steinlechner K, Langer FB et al (2022) Outcome of sleeve gastrectomy converted to Roux-en-Y gastric bypass and one-anastomosis gastric bypass. Obes Surg 32:643–651. https://doi.org/10.1007/s11695-021-05866-0
doi: 10.1007/s11695-021-05866-0 pubmed: 35028871 pmcid: 8866292
Nevo N, Abu-Abeid S, Lahat G et al (2018) Converting a sleeve gastrectomy to a gastric bypass for weight loss failure—is it worth it? Obes Surg 28:364–368. https://doi.org/10.1007/s11695-017-2856-6
doi: 10.1007/s11695-017-2856-6 pubmed: 28891022
Rheinwalt KP, Schipper S, Plamper A et al (2022) Roux-en-Y versus one anastomosis gastric bypass as redo-operations following sleeve gastrectomy: a retrospective study. World J Surg 46:855–864. https://doi.org/10.1007/s00268-021-06424-6
doi: 10.1007/s00268-021-06424-6 pubmed: 34985543
Schafer LW, Larson DE, Melton LJ 3rd et al (1983) The risk of gastric carcinoma after surgical treatment for benign ulcer disease. A population-based study in Olmsted County. Minnesota N Engl J Med 309:1210–1213. https://doi.org/10.1056/NEJM198311173092003
doi: 10.1056/NEJM198311173092003 pubmed: 6633569
Georgiadou D, Sergentanis TN, Nixon A et al (2014) Efficacy and safety of laparoscopic mini gastric bypass. A systematic review. Surg Obes Relat Dis 10:984–991. https://doi.org/10.1016/j.soard.2014.02.009
doi: 10.1016/j.soard.2014.02.009 pubmed: 24913595
Keleidari B, Dehkordi MM, Shahraki MS et al (2021) Bile reflux after one anastomosis gastric bypass surgery: a review study. Annal Med Surg 64:102248. https://doi.org/10.1016/j.amsu.2021.102248
doi: 10.1016/j.amsu.2021.102248
Kassir R, Petrucciani N, Debs T et al (2020) Conversion of one anastomosis gastric bypass (OAGB) to Roux-en-Y gastric bypass (RYGB) for biliary reflux resistant to medical treatment: lessons learned from a retrospective series of 2780 consecutive patients undergoing OAGB. Obes Surg 30:2093–2098. https://doi.org/10.1007/s11695-020-04460-0
doi: 10.1007/s11695-020-04460-0 pubmed: 32052289
Musella M, Susa A, Manno E et al (2017) complications following the mini/one anastomosis gastric bypass (MGB/OAGB): a multi-institutional survey on 2678 patients with a mid-term (5 years) follow-up. Obes Surg 27:2956–2967. https://doi.org/10.1007/s11695-017-2726-2
doi: 10.1007/s11695-017-2726-2 pubmed: 28569357
Kermansaravi M, Shahab &, Shahmiri S, et al One anastomosis/mini-gastric bypass (OAGB/MGB) as revisional surgery following primary restrictive bariatric procedures: a systematic review and meta-analysis. https://doi.org/10.1007/s11695-020
Carandina S (2021) Long-term results of one anastomosis gastric bypass : a single center experience with a minimum follow-up of 10 Years. 3468–3475
Chevallier JM, Arman GA, Guenzi M et al (2015) One thousand single anastomosis (omega loop) gastric bypasses to treat morbid obesity in a 7-year period: outcomes show few complications and good efficacy. Obes Surg 25:951–958. https://doi.org/10.1007/s11695-014-1552-z
doi: 10.1007/s11695-014-1552-z pubmed: 25585612
Winstanley J, Ahmed S, Courtney M et al (2021) One anastomosis gastric bypass in patients with gastrooesophageal reflux disease and/or hiatus hernia. Obes Surg 31:1449–1454. https://doi.org/10.1007/s11695-020-05149-0
doi: 10.1007/s11695-020-05149-0 pubmed: 33405182
Slagter N, M de Heide LJ, Jutte EH, et al Outcomes of the one anastomosis gastric bypass with various biliopancreatic limb lengths: a retrospective single-center cohort study. https://doi.org/10.1007/s11695-021-05555-y/Published
Komaei I, Sarra F, Lazzara C et al (2019) One anastomosis gastric bypass–mini gastric bypass with tailored biliopancreatic limb length formula relative to small bowel length: preliminary results. Obes Surg 29:3062–3070. https://doi.org/10.1007/s11695-019-04019-8
doi: 10.1007/s11695-019-04019-8 pubmed: 31209832

Auteurs

Shlomi Rayman (S)

Department of General Surgery, Assuta Ashdod Public Hospital, affiliated with the Faculty of Health and Science at Ben-Gurion University, Ha-Refu'a St 7, 7747629, Ashdod, Israel. shlomir@assuta.co.il.

Maor Staierman (M)

Department of General Surgery, Assuta Ashdod Public Hospital, affiliated with the Faculty of Health and Science at Ben-Gurion University, Ha-Refu'a St 7, 7747629, Ashdod, Israel.

Dan Assaf (D)

Department of Surgery C, Chaim Sheba Medical Center, Tel Hashomer, Israel, Affiliated with the Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel. Derech Sheba 2, 52662, Ramat-Gan, Israel.

Jacob Rachmuth (J)

Department of General Surgery, Assuta Ashdod Public Hospital, affiliated with the Faculty of Health and Science at Ben-Gurion University, Ha-Refu'a St 7, 7747629, Ashdod, Israel.

Idan Carmeli (I)

Department of General Surgery, Assuta Ashdod Public Hospital, affiliated with the Faculty of Health and Science at Ben-Gurion University, Ha-Refu'a St 7, 7747629, Ashdod, Israel.

Andrei Keidar (A)

Department of General Surgery, Assuta Ashdod Public Hospital, affiliated with the Faculty of Health and Science at Ben-Gurion University, Ha-Refu'a St 7, 7747629, Ashdod, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH